News

View all
Thumbnail image for Shire’s Intuniv hits targets in adult ADHD trial

Shire’s Intuniv hits targets in adult ADHD trial

Data from a Phase III study evaluating Shire’s Intuniv in Japan in adults with attention deficit hyperactivity disorder indicate that the drug could improve symptoms of the condition in this patient group.

20th September 2017

Thumbnail image for EU green light for Novartis’ Rydapt

EU green light for Novartis’ Rydapt

The European Commission has approved Novartis’ Rydapt to treat a certain form of acute myeloid leukaemia (AML) as well as three other rare diseases.

20th September 2017

Thumbnail image for NICE backs use of Opdivo for lung cancer

NICE backs use of Opdivo for lung cancer

Bristol-Myers Squibb’s Opdivo is being recommended by the National Institute for Health and Care Excellence to treat a certain form of lung cancer on the NHS in England, via the Cancer Drugs Fund.

20th September 2017

Web Exclusives

View all
Thumbnail image for Harnessing predictive analytics

Harnessing predictive analytics

Joseph B. Laudano, vice president, medical affairs strategy for Medmeme, takes a look at advances in data mining and metrics analysis

Thumbnail image for Trust in the supply chain

Trust in the supply chain

In a world of increasingly complex pharma supply chains, technology is playing a growing role in helping smooth the relationship between businesses and their suppliers

Thumbnail image for Pregabalin: the battle continues

Pregabalin: the battle continues

A detailed look at the ongoing patent case for Pfizer’s pain drug and what the potentially-landmark ruling could mean for the industry

Thumbnail image for Payment power

Payment power

How to become investigator sites’ payments sponsor of choice

Thumbnail image for Feeling the squeeze?

Feeling the squeeze?

Paul Midgley, director of NHS Insight at Wilmington Healthcare, explains how Capped Expenditure Processes (CEP) will impact both NHS services and pharma sales

Thumbnail image for Going public

Going public

Jaak Peeters, head of Johnson & Johnson Global Public Health, on pharma’s role in supporting global health, fighting epidemics and making medicines accessible

Thumbnail image for Hollow Victory?

Hollow Victory?

The NHS scores better than many other countries in terms of access to health – until you take outcomes into account

Thumbnail image for Intelligent design

Intelligent design

PharmaTimes speaks to AI expert Jackie Hunter about the future of these technologies in R&D

Thought Leadership

View all

Webinars

View all

Designing Pharma organisations for success

Across all industries, people are changing the ways they engage with products, services, and brands. View more...

Wednesday, 28 September 2016 - 11:00 am
George Underwood
FREE - Listen again now - | VIEW NOW

Latest jobs

View all

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download